Literature DB >> 2446576

Cortical glucose utilization patterns in primary degenerative dementias of the anterior and posterior type.

T N Chase1, G H Burrows, E Mohr.   

Abstract

Regional cortical function was evaluated in 13 patients with primary degenerative dementia and six age-matched, neurologically normal control individuals. Five patients were selected on the basis of preponderant signs of posterior dementia, five had mainly signs of anterior dementia, and the remaining three evidenced mixed anterior-posterior cognitive deficits. Positron emission tomographic scans following the intravenous administration of fluorodeoxyglucose revealed a characteristic pattern of abnormalities in each group: those with posterior dementia, as primarily manifested by verbal and visuospatial deficits, had a predominant focus of hypofunction in the posterior parietal and temporal regions; those with the less common anterior dementia, evidenced by prominent personality and social behavioral changes, had their most conspicuous abnormality in the anterior frontal cortex; those with approximately equal signs of anterior and posterior dementia had abnormalities in both anterior frontal and posterior parietal-temporal areas. The results indicate that the primary degenerative dementias may reflect a selective abnormality of the frontal and parietal association corticies. The continuous distribution of cortical involvement in patients with these disorders suggests that diagnostic entities as neuropathologically distinct as Alzheimer's disease (mainly posterior involvement) and Pick's disease (mainly anterior involvement) could share a common pathophysiology. A focusing of histological and biochemical efforts in areas of major functional abnormality could hasten the elucidation of such mechanisms and the development of effective therapies.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2446576     DOI: 10.1016/0167-4943(87)90028-8

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  6 in total

1.  Heterogeneity in Alzheimer's disease: progression rate segregated by distinct neuropsychological and cerebral metabolic profiles.

Authors:  U M Mann; E Mohr; M Gearing; T N Chase
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

Review 2.  The birth and early evolution of the frontotemporal dementia (FTD) concept.

Authors:  Arne Brun; Lars Gustafson
Journal:  J Mol Neurosci       Date:  2011-06-07       Impact factor: 3.444

Review 3.  Neurotransmitter replacement therapy in Alzheimer's disease.

Authors:  E Mohr; T Mendis; I N Rusk; J D Grimes
Journal:  J Psychiatry Neurosci       Date:  1994-01       Impact factor: 6.186

4.  Specificity of changes in cerebral blood flow in patients with frontal lobe dementia.

Authors:  S E Starkstein; R Migliorelli; A Tesón; L Sabe; S Vázquez; M Turjanski; R G Robinson; R Leiguarda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-07       Impact factor: 10.154

5.  Decreased cerebral glucose metabolism associated with mental deterioration in multi-infarct dementia.

Authors:  K Meguro; C Doi; M Ueda; T Yamaguchi; H Matsui; S Kinomura; M Itoh; K Yamada; H Sasaki
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

6.  Altered connectivity among emotion-related brain regions during short-term memory in Alzheimer's disease.

Authors:  R Shayna Rosenbaum; Maura L Furey; Barry Horwitz; Cheryl L Grady
Journal:  Neurobiol Aging       Date:  2008-07-17       Impact factor: 4.673

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.